Dolores Baksh, Innovation Leader, GE Healthcare
"I hope to be able to network with colleagues and members that are attending from industry and from academia. I hope to be able to get people to understand some of the hurdles that we face. I hope to be able to put forth our understanding of the underlying reasons behind the improvement in overall survival without the improvement in progression free survival, as well as our understandings of the potential for combination therapy. Finally, I hope to learn from what looks to be many interesting sessions led by leaders in the field."
James L. Gulley, MD, PhD, FACP, Chief, Genitourinary Malignancies Branch, Director, Medical Oncology Service, Center for Cancer Research, National Cancer Institute